due to their water equivalency (i.e. they cannot be differentiated from tissue), but accurate localization is necessary for comparison of measured dose to dose calculated on CT images. Materials and Methods: We constructed two mock PSDs with CT-radioopaque metal wire used in place of scintillating fibers. Each mock detector was constructed to the specifications of in-vivo PSDs being used at our institution and consisted of a 7 mm graphite spacer, 2 mm of radio-opaque wire coupled to a clear plastic optical fiber contained in black polyethylene jacketing. 2 mm spherical ceramic fiducials were attached at the end of the detector and to either side of the detector 1 cm distal to the wire as surrogates for calculating the location of the 'sensitive volume'. The detectors were attached to an endorectal balloon which was subsequently inserted into an anthropomorphic prostate phantom and inflated. A CT scan (2.5 mm slice thickness, the same used when imaging in-vivo detectors in patients) of the phantom was then acquired, and the resulting images imported into the Pinnacle treatment planning system. A script then determined the location of the active volume by calculating a line between the center of the proximal fiducial and a point halfway between the two distal fiducials (i.e. the center of the optical fiber) and contouring 1 mm diameter circles around the line on slices containing the portion of the line between 8 mm and 10 mm. The locations of the resulting contours were compared to the location of the metal wire. This process was repeated ten times -removing and deflating the balloon, detaching the detectors, and then re-setting up the experiment completely each time. Results: The average deviation in the axial plane between the center of the contours and the center of the metal wire was 0.1 mm in the anterior direction (Figure 1) . The root-mean-square deviation was 0.4 mm. All contours were within 0.8 mm of the actual location. 13 out of 20 measurements were localized to the correct axial slice, and the other 7 were one slice off. Axial discrepancies were considered more important than SI discrepancies because the dose gradient of patient treatment plans lies primarily along the AP direction. The direction and magnitude of the deviation from actual location for all 20 measurements are shown in Figure 1 .
Purpose/Objective: Medical linear accelerators (linacs) capable of delivering flattening filter free (FFF) beams present a promising option for radiotherapy clinics due to potentially reduced treatment times and lower doses out of field. However, successful treatment outcome depends on the accuracy of the commissioning data loaded into treatment planning systems -especially for treatments involving small or composite fields. A comparison of beam data between dosimetry methods is therefore required to assess the uncertainties on dose estimates. Differences in response of different dosimetry methods, primarily due to energy dependence, have been discussed in the literature for conventional flattened (FF) beams. However, it is not obvious that the same differences apply in FFF beams. To assess this, we present measurements of central dosimetric parameters, obtained using three different dosimetry methods in FFF beams. Materials and Methods: Measurements were performed in water for a Varian TrueBeam not yet commissioned for FFF beams. The measurements concerned i) output factors, ii) TPR20:10 ratios, and iii) dose per pulse. Output factors and TPR20:10 measurements were acquired for 6 MV and 10 MV beams operated in FFF mode, using i) a fibre-coupled organic scintillator, ii) a PTW 60003 diamond detector and iii) an IBA CC13 ionization chamber. To accurately determine the increase in instantaneous dose rate when removing the flattening filter, the dose per pulse was measured using the fibre-coupled organic scintillator for FFF as well as FF beams. Results: The table shows measured output factors (mean ± 1 SD) obtained at 90 cm source to surface distance and 10 cm depth. Differences between detectors were significant for large fields, amounting to 3.2 % at the largest. Conversely, differences of up to 2.8 % between the scintillator and diamond were seen for small fields. Measurements of TPR20:10 ratios were more consistent, agreeing to within 0.8 % for the three dosimetry methods. The measured dose per pulse was 2.7 times higher for 6 MV FFF than for 6 MV FF, and 4.6 times higher for 10 MV FFF than for 10 MV FF, comparing well with literature values of FFF beam output (Int J Radiat Oncol Biol Phys 80, 1228 -1237 , 2011 .
Conclusions:
The presented measurements show that detectorinherent differences in output factor measurements are also encountered in FFF beams. The over-response of diamonds has been discussed in the literature for FF beams (Phys Med Biol 57, 4461-4476, 2012) ; similarly, differences between ionization chambers and scintillators have been reported for 6 MV large fields (Med Phys 38, 2140 -2150 , 2011 . We conclude that these findings also apply in FFF beams. However, the needed correction factors for ionization chambers and diamonds are larger for FFF beams due to the higher dose per pulse. To further assess dosimetric uncertainties, a logical next step would be to compare beam data for linacs situated at different clinics, obtained using the same set of equipment. Purpose/Objective: EBT2 and EBT3 radiochromic films are characterized by a high spatial resolution that can't be matched by two-dimensional ion chamber or diode arrays. Thanks to this property they seem to be ideal dosimeters for the verification of TomoTherapy stereotactic body radiation therapy (SBRT) plans. Their response is degraded by two different sources: acquisition process related distortion; inherent dose sensitivity variations. Moreover this nonuniformities convolve with the regular dose fluctuation pattern inherent to helical dose delivery. In this study a protocol that allows to reduce the spatial non-uniformity to a clinically acceptable level was investigated. Materials and Methods: Dose sensitivity variations was quantified for different film batches by delivering a uniform dose distribution with a standard linear accelerator. The frequency range that characterized noise bands was identified with a band-pass filter. 10 TomoTherapy SBRT plans were delivered on EBT2-3 films. Films were digitized with an Epson scanner and the resulting images were converted in net
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